CClinicalTrials.gg
RecruitingNCT06257979POCICOUpdated Jun 18, 2024

Unexpected Positive Cultures in Rotator Cuff Revision Surgery

An interventional study of This study is with minimal risk and minimal constraints due to the addition of questionnaires in Rotator Cuff Repair, sponsored by Elsan. Recruiting at 8 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-18.

Sponsored by Elsan · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

In the context of rotator cuff re-intervention, the impact of Unexpected Positive Cultures (UPC) is not documented, and their management has not been studied, particularly regarding indications for antibiotic therapy, which is currently not a consensus.

A prospective interventional study will be implemented to compare the results of non-randomized patient samples, whether positive or negative, taken during rotator cuff re-intervention. The objective is to assess whether these samples do not affect clinical outcomes and tendon healing rates.

Read the detailed description

Rotator cuff injuries are a common pathology with a 30% prevalence in the general population. If rotator cuff repair fails, patients often experience persistent pain, and bacteria can be detected during the revision period in approximately 30% of cases, even in the absence of septic symptoms. This type of infection, referred to as low-level infection, occurs in around 5% of cases and is frequently implicated as a contributing factor to poor outcomes of the intervention.

Bacteriological samples are routinely collected during revisions, especially for prostheses. The appropriate course of action in cases where these samples test positive, yet there are no signs of infection, remains to be clarified. Notably, administering antibiotics in response to unexpected positive cultures (UPC) during the revision period for total shoulder prostheses does not appear to significantly impact results or infection rates.

In the context of rotator cuff re-interventions, the impact of UPC has not been well-documented. The management of UPC, particularly regarding antibiotic therapy, has not been thoroughly studied and is not currently recommended. Further research is needed to establish guidelines for managing positive cultures in the absence of infection symptoms during rotator cuff re-interventions.

02

Conditions studied

  • Rotator Cuff Repair

Keywords

  • Unexpected Positive Cultures (UPC)
  • Revision cuff repair surgery (RCR)
03

In context

Lead sponsor

Elsan is the lead sponsor of 66 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient, male or female, aged 18 or over
  • Patient requiring re- intervention for Rotator Ruff Revision Surgery for non-healing of the same tendons after a first intervention (delay \<2 years)
  • Patient requiring arthroscopy
  • Patient having had realized a MRI of the shoulder in the 6 previous months
  • Affiliate participant or beneficiary of a social security scheme
  • Participant having been informed and not having objected to the use of their data

Exclusion criteria

Exclusion Criteria:

  • Patient with at least one clinical sign of infection (fever, redness)
  • Patient with a new distant rupture on a healed cuff (> 3 years)
  • Patient with a history of shoulder surgery other than initial Rotator Ruff Surgery
  • Patient having received antibiotic treatment in the 2 weeks preceding inclusion
  • Participant in another research
  • Participant in a period of exclusion from another research still in progress at the time of inclusion
  • Protected participant: an adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant, breastfeeding or parturient woman
  • Participant hospitalized without consent
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
132 participants (estimated)

Study arms

  • Other
    Experimental group

    Operated patients with positive results for their pre-operative microbiological samples.

    Other: This study is with minimal risk and minimal constraints due to the addition of questionnaires

  • Other
    Control group

    Operated patients with negative results for their pre-operative microbiological samples.

    Other: This study is with minimal risk and minimal constraints due to the addition of questionnaires

Interventions

  • OtherThis study is with minimal risk and minimal constraints due to the addition of questionnaires

    In this study, the specific procedures compared to routine care are : * Considering the addition of questionnaires, this study will be prospective. Due to the use of bacteriological samples, it is considered as a minimal-risk research. * The research procedure involves a bacteriological analysis of operative elements (sutures placed during the first intervention, the product of tendon debridement, and the subacromial bursa (cleaning product)) used during the re-intervention. These usually discarded operative samples are collected for bacteriological analysis. * Antibiotic treatment cannot be prescribed immediately after the surgery and during the first month following this re-intervention (time for biofilm formation). As per the protocol, even a positive sample should not lead to the initiation of systematic antibiotic therapy. In the case of identification of a pathogenic microorganism, antibiotic therapy will be prescribed, leading to discontinuation of the study.

    Also known as: Microbiological analysis of samples collected from operated patients: in the presence of UPC, it does not influence the postoperative course, No antibiotics are prescribed during the first month after the operation.

06

What researchers measure

Primary outcomes

  1. Compare the functional recovery of the shoulder at one year after iterative repair of non-healing rotator cuff between patients with unexpected positive cultures and patients with negative results.

    Compare the functional recovery (Yes/No), at one year after iterative repair of non-healing rotator cuff between patients with unexpected positive cultures and patients with negative results using the Constant Score.

    Time frame: at Month 1, Month 3, Month 6 and 1 Year after the re-intervention

  2. Compare the 2 groups on tendon healing, after iterative repair of non-healing of the rotator cuff

    Compare the 2 groups on tendon healing (Yes/No), after iterative repair of non-healing of the rotator cuff using the Constant Score.

    Time frame: at Month 1, Month 3, Month 6 and 1 Year after the re-intervention

  3. Compare the 2 groups on the occurrence of post-operative complications, after iterative repair of non-healing of the rotator cuff

    Compare the 2 groups on the occurrence of post-operative complications (Yes/No), after iterative repair of non-healing of the rotator cuff and list them

    Time frame: up to one year after the re-intervention

  4. Compare the 2 groups on the patient's other functional scores

    Compare the 2 groups on the patient's other functional scores such as SSV and ASES questionnaries

    Time frame: at Month 1, Month 3, Month 6 and 1 Year after the re-intervention

  5. Describe the pathogenic germs found in the positive cultures

    List of pathogenic germs found in the positive samples

    Time frame: at Month 1 after the re-intervention

Secondary outcomes

  1. Sugaya score measured from MRI to assess the influence of positive cultures on tendon healing

    The quality of the repair was assessed using an MRI and the Sugaya classification (French version): Type 1: Normal thickness and echostructure of the rotator cuff. Type 2: Normal thickness and heterogeneous echostructure. Type 3: Thinning without discontinuity. Type 4: Moderate discontinuity. Type 5: Frank discontinuity.

    Time frame: at one year after the re-intervention

  2. Occurrence of complications during the first post-operative year

    List of of complications during the first post-operative year

    Time frame: up to one year after the re-intervention

  3. Functional scores at one year: American Shoulder and Elbow Surgeons Score (ASES)

    ASES score can be viewed as a 100-point scale that evaluates two dimensions of shoulder function: pain and performance in activities of daily living. Each of the two domains make up for 50 of the 100 points.

    Time frame: at one year after the re-intervention

  4. Functional scores at one year: Subjective Shoulder Value (SSV)

    SSV score is defined as the subjective evaluation by the patient of shoulder function, expressed as a percentage of a normal shoulder. This score ranges from 0 to 100%.

    Time frame: at one year after the re-intervention

  5. Pathogenic bacteria detected in the group of patients with positive results

    List of pathogenic bacteria detected in the group of patients with positive results

    Time frame: at Month 1 after the re-intervention

07

Study locations

1 of 8 sites recruiting
  • Hôpital privé La Châtaigneraie ELSAN
    Beaumont, 63110, France
    Not yet recruiting
  • Hôpital privé Saint-Martin
    Caen, 14050, France
    Not yet recruiting
  • Clinique Louis Pasteur
    Essey-lès-Nancy, 54270, France
    • Adrien JACQUOT, MD · Contact
    Not yet recruiting
  • Santy-Lyon-Ramsay
    Lyon, 69008, France
    Not yet recruiting
  • Clinique d'occitanie ELSAN
    Muret, 31600, France
    Not yet recruiting
  • ICR-Kantys
    Nice, 06000, France
    Not yet recruiting
  • Santé Atlantique ELSAN
    Saint-Herblain, 44800, France
    Not yet recruiting
  • Clinique de l'Orangerie
    Strasbourg, France
    Recruiting
08

References and documents

Publications

  • Zhao J, Luo M, Pan J, Liang G, Feng W, Zeng L, Yang W, Liu J. Risk factors affecting rotator cuff retear after arthroscopic repair: a meta-analysis and systematic review. J Shoulder Elbow Surg. 2021 Nov;30(11):2660-2670. doi: 10.1016/j.jse.2021.05.010. Epub 2021 Jun 2. PubMed 34089878 ↗
  • Azar M, Van der Meijden O, Pireau N, Chelli M, Gonzalez JF, Boileau P. Arthroscopic revision cuff repair: do tendons have a second chance to heal? J Shoulder Elbow Surg. 2022 Dec;31(12):2521-2531. doi: 10.1016/j.jse.2022.04.024. Epub 2022 Jun 6. PubMed 35671929 ↗
  • Bonnevialle N, Dauzeres F, Toulemonde J, Elia F, Laffosse JM, Mansat P. Periprosthetic shoulder infection: an overview. EFORT Open Rev. 2017 Apr 27;2(4):104-109. doi: 10.1302/2058-5241.2.160023. eCollection 2017 Apr. PubMed 28507783 ↗
  • Neufeld ME, Lanting BA, Shehata M, Naudie DDR, McCalden RW, Teeter MG, Vasarhelyi EM. The Prevalence and Outcomes of Unexpected Positive Intraoperative Cultures in Presumed Aseptic Revision Knee Arthroplasty. J Arthroplasty. 2022 Nov;37(11):2262-2271. doi: 10.1016/j.arth.2022.05.036. Epub 2022 May 19. PubMed 35598759 ↗
  • Falstie-Jensen T, Lange J, Daugaard H, Sorensen AKB, Ovesen J, Soballe K; ROSA Study Group. Unexpected positive cultures after revision shoulder arthroplasty: does it affect outcome? J Shoulder Elbow Surg. 2021 Jun;30(6):1299-1308. doi: 10.1016/j.jse.2020.12.014. Epub 2021 Feb 3. PubMed 33548396 ↗
  • Hodakowski AJ, Cohn MR, Mehta N, Menendez ME, McCormick JR, Garrigues GE. An evidence-based approach to managing unexpected positive cultures in shoulder arthroplasty. J Shoulder Elbow Surg. 2022 Oct;31(10):2176-2186. doi: 10.1016/j.jse.2022.03.019. Epub 2022 May 2. PubMed 35513254 ↗
  • Constant CR, Murley AH. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987 Jan;(214):160-4. PubMed 3791738 ↗
  • Sugaya H, Maeda K, Matsuki K, Moriishi J. Functional and structural outcome after arthroscopic full-thickness rotator cuff repair: single-row versus dual-row fixation. Arthroscopy. 2005 Nov;21(11):1307-16. doi: 10.1016/j.arthro.2005.08.011. PubMed 16325080 ↗
  • Angst F, Goldhahn J, Drerup S, Aeschlimann A, Schwyzer HK, Simmen BR. Responsiveness of six outcome assessment instruments in total shoulder arthroplasty. Arthritis Rheum. 2008 Mar 15;59(3):391-8. doi: 10.1002/art.23318. PubMed 18311752 ↗
  • Gilbart MK, Gerber C. Comparison of the subjective shoulder value and the Constant score. J Shoulder Elbow Surg. 2007 Nov-Dec;16(6):717-21. doi: 10.1016/j.jse.2007.02.123. PubMed 18061114 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06257979
Lead sponsor
Elsan
Responsible party
Sponsor
First posted
Feb 14, 2024
Start date
Feb 27, 2024
Primary completion
Feb 15, 2028 (estimated)
Completion
Mar 15, 2028 (estimated)
Last update
Jun 18, 2024

Study contacts

Albatoul ZAKARIA, PhD
Contact
zakaria@elsan.care
0033 6 49 77 17 52
Maxime ANTONI, MD
study director · Clinique de l'Orangerie-Strasbourg

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion